What is Jardiance?
Jardiance (empagliflozin) is a prescription SGLT2 inhibitor used to manage type 2 diabetes and lower the risk of heart disease. It works by preventing glucose reabsorption in the kidneys, allowing excess sugar to be eliminated through urine. This helps maintain healthy blood sugar levels while also supporting cardiovascular health. Jardiance may also contribute to weight loss and reduce the risk of kidney disease progression in diabetic patients. Typically taken once daily, it should be used as directed by a doctor. Jardiance is not recommended for type 1 diabetes or severe kidney conditions.